In Caucasians, maturity-onset diabetes of the young (MODY) is mostly caused by mutations in the hepatocyte nuclear factor (HNF)-1a (MODY3) and glucokinase (MODY2) genes. Most Japanese MODY patients, however, are not linked to known MODY genes. In this study, we examined the genetic and clinical characteristics of Chinese subjects with MODY. The study included 146 unrelated families fulfilling the minimum criteria for MODY: two consecutive generations of type II diabetes with at least one member diagnosed under the age of 25. We screened for mutations in the HNF-4a (MODY1), MODY2 and MODY3 genes by direct sequencing. Antibody to glutamic acid decarboxylase (GAD-Ab) was measured in subjects with MODY of unknown cause (MODYX). Insulin resistance index and other clinical data were compared in sex-, age-and duration-matched MODY3 and MODYX patients. In all, 13 families had MODY3 mutations and two had MODY2 mutations. No MODY1 mutation was found. Four of the 12 different MODY3 mutations were newly identified novel mutations (Q243E, A311D, P379R and P488fsdelC). In subjects with MODYX, 3% were GAD-Ab positive and 60% were overweight. Compared to MODY3 patients, MODYX patients had higher body mass index (Po0.02), higher insulin resistance index (P ¼ 0.001) and triglyceride level (Po0.02), lower HDL level (P ¼ 0.001) and more hypertension (Po0.05), but no significant difference in the prevalence of diabetic complications. In conclusion, MODY3 and MODY2 account for only 9 and 1%, respectively, of Chinese MODY. A majority of Chinese MODY patients are due to defects in unknown genes and appear to be characterized by insulin resistance.
Introduction
Type II diabetes mellitus (T2DM) refers to a diverse group of metabolic diseases, which are characterized by both impaired b-cell function and insulin resistance. In Hong Kong, its prevalence is reaching alarming dimensions (9.8% among adults). 1 Studies involving over 350 000 persons have shown that diabetic patients have significant reductions in life expectancy. 2 Furthermore, the younger an individual is diagnosed with diabetes, the larger reductions in life expectancy he or she will suffer. Knowledge of the etiology of T2DM will help in the primary prevention of diabetes and its complications, which are important public health priorities. However, despite extensive research in the recent decade, the major genes causing common T2DM remain elusive. Maturity-onset diabetes of the young (MODY) is a monogenic type of T2DM, characterized by an early age of onset (usually at p25 years of age) and an autosomal dominant mode of inheritance. To date, six genes have been identified to be responsible for MODY. These include the hepatocyte nuclear factor (HNF)-4a gene (MODY1), 3 glucokinase (GCK) gene (MODY2), 4 HNF-1a gene (MODY3), 5 insulin promoter factor-1 (IPF-1) gene (MODY4), 6 HNF-1b gene (MODY5) 7 and neurogenic differentiation factor 1 (NEUROD1) gene (MODY6). 8 The identification of these MODY genes has made considerable contribution to our understanding of the pathogenesis of common T2DM. MODY3 and MODY2 are the two most prevalent forms, accounting for more than 80% of MODY patients in Caucasians. 9 Mutations in the MODY1 gene are less common, and are found in one out of 57 in Japanese subjects with MODY. 10 Other subtypes are rare disorders reported only in a few families. 6 -8 Previous studies suggest that about 80% of Japanese MODY patients cannot be explained by known MODY genes. 11 Hence, there is a need for more extensive genetic studies on Asian patients with MODY. In Hong Kong Chinese, MODY3 and MODY2 mutations were found to be responsible for 5 and 4%, respectively, of familial T2DM presenting before the age of 40. 12 Our previous study on 50 MODY families revealed the prevalence of MODY3 to be 12%. 13 However, due to the small number of MODY families included, the actual prevalence of Chinese MODY subtypes and their clinical characteristics remain to be ascertained. In this study, we performed the screening for mutations in the MODY1, MODY2 and MODY3 genes in 146 unrelated clinical MODY families; we also characterized the phenotypes of MODY3 (the most commonly identified cause of MODY) and MODY with unknown cause (MODYX).
Subjects and methods
Subjects and clinical studies Building upon our previous study of 50 Chinese MODY families, 13 the current study collected an additional 96
Chinese MODY families from seven diabetes centers in Hong Kong, bringing our combined sample up to 146 families. All these families fulfilled the minimal criteria for MODY: two consecutive generations of type II diabetes with at least one member diagnosed at p25 years of age. 14 All subjects gave informed consent and the protocol was approved by the Ethics Committee, The University of Hong Kong.
The following clinical data were obtained from each subject: age, duration of diabetes, treatment, body mass index (BMI), waist hip ratio (WHR), blood pressure, fasting plasma glucose (FPG), glycosylated hemoglobin (HbA 1 c), lipid profile (total, LDL and HDL cholesterol and triglyceride), serum alanine aminotransferase (ALT), albumin, creatinine and evidence of diabetic microvascular and macrovascular complications, assessed as described previously.
14,15 A blood sample was also taken for DNA extraction and determinations of antibody to glutamic acid decarboxylase (GAD-Ab) by enzyme-linked immunosorbent assay (Roche Diagnostics, Mannheim, Germany) and fasting C-peptide by radioimmunoassay (DiaSorin Corporation Inc., MN, USA). Subjects with BMI X25 kg/ m 2 were considered as overweight. Since over 25% of the patients were on insulin, insulin resistance was assessed by an index modified from the homeostasis model assessment for insulin resistance index (HOMA IR ¼ FPG Â fasting insulin/22.5), using instead the product of FPG and fasting Cpeptide. 16, 17 Screening for mutations in the MODY1, MODY2 and MODY3 genes The exons, flanking introns and minimal promoter of the MODY1, MODY2 and MODY3 genes were amplified by polymerase chain reaction (PCR) as described previously. 12 
Results

Identification of mutations
In addition to the six previously reported MODY3 families, 13 we also found two MODY2 families in the first 50 MODY families analyzed. No MODY1 family was detected. In view of the expected low frequency of MODY1 mutations, the other 96 MODY families were only screened for mutations in the MODY2 and MODY3 genes. Seven MODY3 families, but no MODY2 families, were found in the expanded MODY cohort. The mutations identified from screening of 146 families are listed in Table 1 . MODY3 mutations Q243E, A311D, P379R and P488fsdelC were novel and had not been reported previously.
Out of the 15 MODY3 or MODY2 families, nine had family members recruited for cosegregation study ( Figure 1 ). Cosegregation of a mutation with diabetes was seen in MODY3 families #37, #113, #41, #212, #217, #236 and #249 (Figure 1a , c, d and f -i). In these seven families, mutations were detected in the probands and all the other 17 affected family members with DNA available, including seven parents, seven siblings, two grandparents and one aunt. None of the 12 nondiabetic family members carried the mutations. Segregation was inconclusive in Family #52 and #194 (Figure 1b and e) . In these two families, several diabetic relatives did not carry the mutations. For the other six families, Family #9, #26, #97, #101, #235 and #238, DNA from family members with diabetes could not be obtained for study.
Clinical characteristics of Chinese MODY3 and MODYX subjects One MODY3 family (#194) and 45 of 131 MODYX families had bilineal inheritance of T2DM. In the 13 MODY3 families, there were 36 diabetic subjects with DNA available, and 33 out of the 36 (92%) diabetic subjects were MODY3 mutation carriers. The BMI of 33 diabetic MODY3 mutation carriers was 22.2273.31 kg/m 2 . In all, 21 of these subjects including the 13 probands were diagnosed under the age of 25; the age of diagnosis of the remaining 12 subjects ranged from 30 to 67 years. The BMI of the 131 MODYX probands was 26.3574.77 kg/m 2 , with 60% of them being overweight. To evaluate the contribution of autoimmunity to the pathogenesis of MODYX, GAD-Ab was measured and four (3%) were found to be positive.
To better define the phenotypic characteristics of Chinese MODY3 and MODYX, we compared 21 MODY3 mutation carriers with the presentation of diabetes at p25 years from 13 families with 63 sex-, age-and durationmatched MODYX probands who were GAD-Ab negative ( Table 2 ). MODYX subjects had higher BMI, higher prevalence of hypertension and, being overweight, higher triglyceride and lower HDL levels than MODY3 subjects. Moreover, MODYX subjects had higher levels of FPG, HbA 1c , fasting C-peptide and insulin resistance index. The difference in insulin resistance index remained significant after being adjusted for HbA 1c (Po0.001). No difference was observed in the levels of serum albumin, ALT and creatinine, or the prevalence of diabetic complications. There was no significant difference in the percentage of patients requiring insulin or oral hypoglycemic agents (OHA), although fewer patients with MODYX could be controlled with diet alone. 
Discussion
In this study, the prevalence of MODY3 and MODY2 was only 9 and 1%, respectively, in 146 unrelated Chinese MODY families. Among the MODY3 mutations, G20R, P112L, R171X, Q176X and P379fsdelCT have been shown to impair or cause a loss in HNF-1a transactivation activity. 13 The intronic mutation IVS7nt-6 G-A has been reported to cause abnormal splicing of HNF-1a. 18 The other intronic mutation IVS5nt þ 2 T-A is at a splice donor site and would affect splicing. The frameshift mutation P488fsdelC generates a truncated protein, which loses about 30% of transactivation domain. The missense mutations R203H, Q243E, A311D and P379R are predicted to change the protein structure, according to the Chou- Figure 1 Pedigrees of families with MODY3 and MODY2 mutations. K, diabetic female; ', diabetic male; J&, subjects with normal glucose tolerance; , untested subjects; s, Proband. Age at diagnosis (years) and genotype, if known, are indicated. N, normal; M, mutation.
Fasman plot. 19 The MODY2 mutation Q239R, which has been previously reported, 12 changes a residue that is conserved in human, rat and mouse. The non-cosegregation of A311D and Q239R with diabetes could not exclude their diabetogenic role, because the two families had bilineal inheritance of T2DM (Figure 1b and e). In these two families, diabetes in the members who did not carry the mutation A311D or Q239R might have been caused by an unknown diabetic gene inherited from the diabetic parent without the respective MODY gene mutation. None of the mutations was detected in the 100 nondiabetic controls and, based on the family cosegregation studies, reported functional studies or anticipated changes in amino acids, all mutations are likely to have functional significance. We have not screened for mutations in the MODY4, MODY5 or MODY6 genes. These subtypes are rare, and have been excluded in Japanese MODY families. 20, 21 Furthermore, MODY5 is associated with renal dysfunction due to defects in kidney development, which were not present in our MODY patients. Therefore, these subtypes of MODY are unlikely to contribute to diabetes in a significant proportion of our MODY families, and about 90% of our Chinese MODY families are not linked to known MODY genes. However, since 45 of the 131 MODYX families have bilineal transmission of diabetes, it is possible that these MODYX families, despite fitting the minimal MODY criteria, may be early-onset polygenic T2DM that, through chance, has resulted in an apparently autosomal dominant pattern of inheritance.
It is interesting to note that only 21 of the 33 MODY3 mutation carriers had diagnosis of diabetes at p25 years of age. The other 12 MODY3 mutation carriers, despite the presence of a MODY3 mutation, were actually diagnosed at a later age, ranging from 30 to 67 years, and would be considered clinically as early-onset or even late-onset type II diabetes.
During the past decade, an increasing frequency in the occurrence of T2DM has been reported in adolescents, and this increase seems to parallel the increase in prevalence of obesity. The majority of our MODYX subjects were overweight, suggesting an important role of excess adiposity in the pathogenesis of MODYX in our population, as in common T2DM. As only 3% of these MODYX subjects were GAD-antibody positive, autoimmunity is apparently not a major underlying factor of MODYX in Chinese.
MODY3 subjects had similar liver and kidney function, and frequency of diabetic complications, as age-and On the other hand, over half of the MODYX subjects were overweight, compared to only 24% in the MODY3 subjects. Furthermore, the higher BMI and triglyceride, lower HDL and a higher prevalence of hypertension in MODYX subjects suggested the presence of greater insulin resistance compared to the MODY3 subjects. This was confirmed by the presence of a higher insulin resistance index that was independent of the difference in glycemic control. Taken together, these data suggest that the insulin resistance syndrome forms a major part of our MODYX phenotype. This was also observed in Caucasian subjects with earlyonset T2DM unlinked to known MODY genes. 24 In conclusion, consistent with studies in Japanese, 11 this study suggests that MODYX accounts for 80 -90% of clinical MODY cases in Asians. Thus, we propose that, in contrast to findings in Caucasians, 9 the major gene for MODY in Asians remains to be identified. We have shown that excess adiposity and insulin resistance are common features of Chinese patients with MODYX. The elucidation of the molecular genetics of MODYX is likely to result in better understanding of the pathogenesis of obesity, insulin resistance and common T2DM.
